neostigmine has been researched along with Neurodegenerative Diseases in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalb, A | 1 |
| von Haefen, C | 1 |
| Sifringer, M | 1 |
| Tegethoff, A | 1 |
| Paeschke, N | 1 |
| Kostova, M | 1 |
| Feldheiser, A | 1 |
| Spies, CD | 1 |
1 other study available for neostigmine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Acetylcholinesterase inhibitors reduce neuroinflammation and -degeneration in the cortex and hippocampus of a surgery stress rat model.
Topics: Animals; Anti-Inflammatory Agents; Cerebral Cortex; Cholinesterase Inhibitors; Drug Evaluation, Prec | 2013 |